Skip to main content

Topic

Drug Compounding

46 published works

  1. Focus on Regulation

    New Guidance Makes Clear that FDA Is Focused on Insanitary Conditions at Pharmacy Compounders

    By Robert Church, Jim Johnson, Christopher Fanelli

    Today, FDA published yet another draft guidance targeting drug compounders, entitled Insanitary Conditions at Compounding Facilities (the Draft Guidance). Notably, it makes clear to pharmacy compounders that although they may…

  2. Health Law Update

    FDA Committee to Continue Considering Drug Compounding Issues

    By Lee H. Rosebush, Dena Kessler

    The advisory committee tasked with providing advice on medical, scientific and technical issues to the Food and Drug Administration (FDA) on compounded drugs is slated to continue its examination of…

  3. Health Law Update

    FDA Establishes Docket for Public Comments on Drug Compounding

    By Lee H. Rosebush, Nita Garg

    The Food and Drug Administration (FDA) recently announced a new docket for public comments on the compounding of human drug products under sections 503A and 503B of the Federal Food,…

  4. Health Law Update

    FDA Issues Draft Memorandum of Understanding for 503A Drug Compounding

    By Lee H. Rosebush, Cory J. Fox, Dena Kessler

    Included in the flurry of guidance documents recently issued by the FDA concerning human drug compounding is a long-awaited document of great importance to mail-order pharmacy compounders and entities that…

  5. Health Law Update

    FDA Guidance Documents Change Compounding Landscape

    By Lee H. Rosebush, Cory J. Fox, Nita Garg, Dena Kessler

    Almost a year and a half after adoption of the Drug Quality and Security Act (DQSA) in November 2013, which revised federal oversight of drug compounding, the Food and Drug…

  6. Sentencing Law and Policy

    Cloudy with (less of) a chance of executions in Georgia

    By Douglas Berman

    Main March 4, 2015Cloudy with (less of) a chance of executions in GeorgiaAs reported in this Time piece, headlined "Georgia Postpones 2 Executions Over ‘Cloudy’ Drugs," the forecast in the…

  7. Focus on Regulation

    FDA Publishes Draft Guidances and Memorandum of Understanding on Drug Compounding and Repackaging

    By Mike Druckman, David Fox, Philip Katz, Delia A. Deschaine, Sari Bourne

    On February 13, 2015, FDA issued four draft guidance documents and a draft memorandum of understanding (MOU) regarding the compounding of drug and biological products and the regulation of outsourcing…

  8. Health Law Update

    Now’s the Time to Comment on the FDA’s New Draft Documents on Compounding Policy

    By Lee H. Rosebush, Cory J. Fox

    The U.S. Food and Drug Administration (FDA) has released five new draft documents related to drug compounding and repackaging by “outsourcing facilities,” state-licensed pharmacies, federal facilities and other healthcare entities.…

  9. Health Industry Washington Watch

    OIG Reviews Oversight of Compounded Pharmaceuticals Used in Hospitals

    By Debra A. McCurdy

    The OIG has issued another report examining the safety of compounded sterile preparations (CSPs) used in hospitals, in response to a 2012 meningitis outbreak caused by contaminated injections. This report,…

  10. Focus on Regulation

    FDA Issues Interim cGMP Guidance for Outsourcing Facilities

    By Mike Druckman, Jim Johnson, Michael Moskowitz

    On July 1, the Food and Drug Administration (FDA) issued interim guidance describing the Agency’s expectations for compliance with current Good Manufacturing Practice (cGMP) requirements for compounding outsourcing facilities under…